Sanctuary Advisors LLC Lowers Position in Cardinal Health, Inc. $CAH

Sanctuary Advisors LLC cut its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 3.8% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 63,090 shares of the company’s stock after selling 2,508 shares during the quarter. Sanctuary Advisors LLC’s holdings in Cardinal Health were worth $13,331,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in CAH. Redhawk Wealth Advisors Inc. lifted its position in Cardinal Health by 0.5% during the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock valued at $1,902,000 after buying an additional 48 shares during the period. HF Advisory Group LLC grew its position in shares of Cardinal Health by 0.9% in the 4th quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock worth $1,074,000 after buying an additional 49 shares during the period. Kathmere Capital Management LLC increased its stake in shares of Cardinal Health by 1.2% in the 1st quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company’s stock worth $896,000 after acquiring an additional 49 shares in the last quarter. Hillsdale Investment Management Inc. lifted its position in Cardinal Health by 0.9% during the 4th quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock valued at $1,184,000 after acquiring an additional 50 shares during the period. Finally, V Square Quantitative Management LLC lifted its position in Cardinal Health by 2.6% during the 1st quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company’s stock valued at $423,000 after acquiring an additional 50 shares during the period. Institutional investors own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of recent research reports. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. Wells Fargo & Company lowered their target price on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Weiss Ratings cut Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. Bank of America raised their price objective on Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research report on Thursday, July 2nd. Finally, Zacks Research cut Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $249.13.

Cardinal Health Stock Performance

NYSE:CAH opened at $228.88 on Friday. The firm has a market cap of $53.61 billion, a P/E ratio of 35.00, a P/E/G ratio of 1.10 and a beta of 0.49. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $243.21. The firm has a 50-day simple moving average of $215.36 and a two-hundred day simple moving average of $213.66.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter in the prior year, the firm posted $2.35 earnings per share. The business’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 10.77 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were issued a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date was Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is presently 31.50%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.